baber/WOPTO huggingface dataset:
Patent DE-69405976-T2 (DE)
Inventor: KERR PAUL
IPC: H04L29/08
Filed: 1994-02-02
Granted: 1998-01-29
Abstract: A computer-based media data processor for controlling transmission of digitized media data in a packet switching network. When the processor receives a request from a network client node for presentation of specified media data stream presentation unit sequences the processor in response retrieves media data from a corresponding media access location, determines the media data type of each presentation unit in the retrieved media data, and designates each retrieved presentation unit to a specified media data presentation unit sequence based on the media data type determination for that presentation unit. The processor then assembles a sequence of presentation descriptors for each of the specified presentation unit sequences, all presentation descriptors in an assembled sequence being of a common media data type, and then assembles transmission presentation unit packets each composed of at least a portion of a presentation descriptor and its media data, all presentation descriptors and media data in an assembled packet being of a common media data type. The assembled packets are then released for transmission via the network to the client processing node requesting presentation of the specified presentation unit sequences.
Patent DE-69413009-T2 (DE)
Inventor: HART CHARLES E
IPC: C12N15/09
Filed: 1994-02-17
Granted: 1999-03-25
Abstract: Methods of inhibiting intimal hyperplasia in the vasculature of mammals, including primates, are disclosed. The methods comprise administering to the mammal an anti-PDGF receptor antibody, such as an anti-PDGF-alpha receptor antibody or an anti-PDGF-beta receptor antibody. The methods are useful in reducing intimal hyperplasia due to, for example, vascular injuries resulting from angioplasty, endarterectomy, reduction atherectomy or anastomosis of a vascular graft.
Patent DE-69413085-T2 (DE)
Inventor: CONNELL RICHARD D
IPC: A61K31/401
Filed: 1994-01-28
Granted: 1999-02-04
Abstract: Compounds which suppress human T-lymphocyte proliferation are disclosed. The active compounds essentially contain at least the following structure: <CHEM>
Patent DE-69413923-T2 (DE)
Inventor: WARANIS ROBERT PAUL
IPC: A61K9/00
Filed: 1994-09-29
Granted: 1999-05-12
Abstract: Disclosed herein is an aqueous, injectable rapamycin solution comprising 40 to 75 volume percent of a concentrate solution of rapamycin in propylene glycol, at concentrations of rapamycin ranging from 0.25 mg/ml to 8 mg/ml, in combination with a diluent solution comprising water, wherein the diluent comprises 60 to 25 volume percent of the combined solution and the concentration of rapamycin in the combined solution ranges from 0.1mg/ml to 4 mg/ml.
Patent DE-69418691-T2 (DE)
Inventor: MANESS JAMES E
IPC: F17C5/06
Filed: 1994-10-27
Granted: 1999-12-23
Abstract: The method of filling a chamber in a container with gas, comprises the steps of forming a seal between a fill head and the container by indenting material around an opening in the container with the fill head. It involves conducting a flow of gas through the fill head and into the chamber in the container through the opening in the container, and blocking gas flow through the seal between the fill heads and the container by engagement of the fill head with the indented material of the container around the opening in the container during flow through the fill head. The step of forming a seal between the fill head and the container by indenting material around an opening in the container with the fill head includes plastically deforming the material around the opening in the container with a ridge which extends around an opening in the fill head.
Patent DE-69421612-T2 (DE)
Inventor: BARAVIAN JEAN
IPC: D04H3/009
Filed: 1994-07-29
Granted: 2001-05-03
Abstract: Non-woven sheet of continuous interconnected filaments is produced from bi-constituted filaments of less than 4 dtex comprising two interconnected elemental filament components of different polymers. Differential shrinkage is imparted to the filaments to produce a curl frequency of 3-30 curls per cm., 50-400 percent filament bunching and formation of a non-woven sheet weighing 10-400 grams per metre. The sheet is subjected to water jets at a pressure of 50-300 X 10 Pa to interface and entangle the curled filaments and separate the interconnected elemental filament components from each other. The resulting non-woven sheet is specifically claimed. <IMAGE>
Patent DE-69429723-T2 (DE)
Inventor: YOUNG A
IPC: C07K19/00
Filed: 1994-06-06
Granted: 2002-09-26
Abstract: The present invention relates to stress proteins and methods of modulating an individual's immune response. In particular, it relates to the use of such stress proteins in immune therapy and prophylaxis, which results in an induction or enhancement of an individual's immune response and as an immunotherapeutic agent which results in a decrease of an individual's immune response to his or her own cells. The present invention also relates to compositions comprising a stress protein joined to another component, such as a fusion protein in which a stress protein is fused to an antigen.
Patent DE-69430118-T2 (DE)
Inventor: SHIOTA YUSUKE
IPC: C02F11/08
Filed: 1994-12-28
Granted: 2002-08-29
Abstract: This invention relates to a catalyst for processing waste water, which is prepared from an oxide and/or a composite oxide of manganese; an oxide and/or composite oxide of at least one metal selected from the group consisting of iron, titanium and zirconium; and whenever necessary, a precious metal. The catalyst is used to subject waste water to wet oxidation by an O2-containing gas at a pressure at which the waste water keeps a liquid phase.
Patent DE-69504565-T2 (DE)
Inventor: MENEGAZZO ZACCARIA
IPC: B60J1/10
Filed: 1995-04-18
Granted: 1999-02-04
Abstract: Easily breakable glass pane for emergency exits or the like, comprising at least one first sheet (10) that is provided with at least one hole (11) and is joined to at least one second sheet (13) having no holes. The pane constituted by said sheets (10,13) is perimetrically shaped so that only the second sheet (13) is mounted in a perimetric frame (15). <IMAGE>
Patent DE-69505362-T2 (DE)
Inventor: GASTER LARAMIE
IPC: C07C245/02
Filed: 1995-03-09
Granted: 1999-04-29
Abstract: Compounds of formula (I), processes for their preparation and their use as CNS agents are disclosed, in which R<1> is hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, COC1-6alkyl, C1-6alkoxy, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, C1-6alkoxy C1-6alkoxy, acyl, nitro, trifluoromethyl, cyano, SR<9>, SOR<9>, SO2R<9>, SO2NR<10>R<11>, CO2R<10>, CONR<10>R<11>, CO2NR<10>R<11>, CONR<10>(CH2)pCO2R<11>, (CH2)pNR<10>R<11>, (CH2)pCONR<10>R<11>, (CH2)pCO2C1-6alkyl, NR<10>R<11>, NR<10>CO2R<11>, NR<10>CONR<10>R<11>, CR<10>=NOR<11>, CNR<10>=NOR<11>, where R<10> and R<11> are independently hydrogen or C1-6alkyl and p is 1 to 3; R<2> and R<3> are independently hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkenyl, C1-6alkoxy, acyl, aryl, acyloxy, hydroxy, nitro, trifluoromethyl, cyano, CO2R<10>, CONR<10>R<11>, NR<10>R<11> where R<10> and R<11> are independently hydrogen or C1-6alkyl; R<4> and R<5> are independently hydrogen or C1-6alkyl; R<6> is hydrogen, halogen, hydroxy, C1-6alkyl or C1-6alkoxy; R<7> and R<8> are independently hydrogen, C1-6alkyl, aralkyl, or together with the nitrogen atom to which they are attached form an optionally substituted 5-7-membered heterocyclic ring containing one or two heteroatoms selected from oxygen, nitrogen or sulphur; A is CONH or NHCO; B is oxygen, S(O)p where p is 0, 1 or 2, or B is NR<12> where R<12 is hydrogen or C>1-6<alkyl; m is 2 to 4; and n is 1 or 2.
Patent DE-69524090-T2 (DE)
Inventor: IKENOYA TADAKATSU
IPC: B65D85/72
Filed: 1995-05-18
Granted: 2002-04-18
Abstract: A packaging container comprising a packaging material including a paper substrate (13), an intermediate layer, an outermost layer (15) and an innermost layer (14) and having opposite side edges which overlap each other so that the outermost layer and the innermost layer of the packaging material face each other. A bending portion (19) is interposed between the outermost layer (15) and the innermost layer (14) by folding the bending portion joined with these layers. The outermost layer and the intermediate layer are made of resins which have compatibility with each other. The bending portion is formed by projecting the intermediate layer and the innermost layer from one side edge of the paper substrate and the outermost layer. <IMAGE>
Patent DE-69528211-T2 (DE)
Inventor: MARTIN WALLACE ANTHONY
IPC: B29C33/06
Filed: 1995-06-09
Granted: 2003-01-23
Abstract: The present invention provides a method and apparatus for partially curing a polymerizable monomer or monomer mixture to form a soft contact lens. The apparatus includes a clamping member and a radiant energy source.
Patent DE-69534080-T2 (DE)
Inventor: BREM HENRY
IPC: A61K9/22
Filed: 1995-08-02
Granted: 2006-04-13
Abstract: A method and devices for localized delivery of a chemotherapeutic agent to solid tumors, wherein the agent does not cross the blood-brain barrier and is characterized by poor bioavailability and/or short half-lives in vivo, are described. The devices consist of reservoirs which release drug over an extended time period while at the same time preserving the bioactivity and bioavailability of the agent. In the most preferred embodiment, the device consists of biodegradable polymeric matrixes, although reservoirs can also be formulated from non-biodegradable polymers or reservoirs connected to implanted infusion pumps. The devices are implanted within or immediately adjacent the tumors to be treated or the site where they have been surgically removed. The examples demonstrate the efficacy of paclitaxel and camptothecin delivered in polymeric implants prepared by compression molding of biodegradable and non-biodegradable polymers, respectively. The results are highly statistically significant.
Patent DE-69600029-T2 (DE)
Inventor: HAEMMERLIN BERNARD
IPC: B62B1/18
Filed: 1996-01-05
Granted: 1998-02-05
Abstract: The wheelbarrow is formed from a shell (1), two shafts (2) and an assembly of feet and wheel supports (3). The wheel (4) is pivoted on the feet and wheel support and their pivoting is limited by a deformable compression spring (5). The wheel pivot mounting is made by a rigid pivoting support (6) partially surrounding the wheel. The wheel axle (7) is carried by this support which is pivoted by a hub (8) in the wheel assembly end support in front of the wheel axle. The rigid pivoting support is in the shape of a stirrup whose webs form at their end the wheel axle support. Their opposite closed end is provided with a support (9) engaging an end of the compression spring which is fixed on the end stop (10).
Patent DE-69605434-T2 (DE)
Inventor: HAEGEMAN JOHNY
IPC: B01F3/04
Filed: 1996-09-25
Granted: 2000-07-13
Abstract: PCT No. PCT/BE96/00099 Sec. 371 Date Feb. 26, 1998 Sec. 102(e) Date Feb. 26, 1998 PCT Filed Sep. 25, 1996 PCT Pub. No. WO97/11772 PCT Pub. Date Apr. 3, 1997The apparatus comprises a motor (16) which is mounted on a float and in which the motor drives an impeller device (20) which extends below the liquid surface (11), with the motor (16) being mounted in a chamber (12) which is fully sealed from the liquid and which serves as a float (10). The apparatus may be fitted with a supply conduit (30) in order to bring gas, such as air, from above the liquid surface to the vicinity of the impeller device (20). The apparatus may be used for the treatment, mixing and/or aeration of liquids such as for example waste water.
Patent DE-69610373-T2 (DE)
Inventor: BAUMANN HARALD
IPC: C08F8/00
Filed: 1996-07-05
Granted: 2001-05-23
Abstract: This invention relates to a binder containing the units A, B, C, D and E, wherein A is present in an amount of 10 to 60 mole% and is of the formula <CHEM>  B is present in an amount of 1 to 30 mole% and is of the formula <CHEM>  C is present in an amount of 5 to 60 mole% and is of the formula <CHEM>  D is present in an amount of 0 to 60 mole% and is of the formula <CHEM> and E is present in an amount of 1 to 40 mole% and is of the formula   <CHEM>  wherein     X is an aliphatic, aromatic or araliphatic spacer group,   R<1> is hydrogen or an aliphatic, aromatic or araliphatic group, R<2>, R<3> and R<4> are hydrogen or alkyl groups with carbon numbers of from 1 to 18 and Y is a saturated or unsaturated chain- or ring-shaped spacer group,   and photosensitive compositions containing this binder.
Patent DE-69613275-T2 (DE)
Inventor: GUISELIN OLIVIER
IPC: B32B27/36
Filed: 1996-05-29
Granted: 2002-04-25
Abstract: A transparent substrate (1) has a thin film stack including a (pref. doped metal oxide or metal) layer (4) which is reflective in the IR and/or solar radiation region and which is located between first and second dielectric coatings (3,6). The novelty is that an intermediate layer (2) of refractive index at least 0.07 (pref. at least 0.12) lower than that of the substrate (1) is provided between the substrate (1) and the thin film stack. Also claimed are (i) low emission or sun-shielding multiple glazing incorporating at least one substrate as described above; (ii) low emission double glazing incorporating the above substrate and having an emissivity of max 0.035, a light transmission (TL) of at least 78% and a reflection colour saturation value (c*) of max. 4; and (iii) laminated glazing incorporating the above substrate and having sun-shielding properties and/or heating properties by provision of current leads for one or more metallic layers.
Patent DE-69628658-T2 (DE)
Inventor: WIELINGA HENK
IPC: F16F7/12
Filed: 1996-09-11
Granted: 2004-04-29
Abstract: PCT No. PCT/SE96/01134 Sec. 371 Date May 7, 1998 Sec. 102(e) Date May 7, 1998 PCT Filed Sep. 11, 1996 PCT Pub. No. WO97/10098 PCT Pub. Date Mar. 20, 1997A honeycomb block comprises three sections of honeycomb elements characterized in that the cell size of each honeycomb element section decreases from a large size in one section to a smaller size in the neighboring sections and an even smaller size in the third section. The honeycomb block may be fabricated from strips of cardboard which are glued together to form the honeycomb cell structure. The honeycomb block may be used as an impact force absorbing element in a door of a vehicle where the cell size in each honeycomb element section decreases from a large size in one section to a smaller size in the neighboring section and the smallest sized cells is facing inward with respect to the passenger compartment of the vehicle.
Patent DE-69635351-T2 (DE)
Inventor: RACZ JUN GABOR J
IPC: A61M5/32
Filed: 1996-11-14
Granted: 2006-08-03
Abstract: An improved needle for use in administering anesthetics, analgesic medications, and the like into the spinal canal through the dura of the spinal cord into the subarachnoid space. The needle comprising a cannula including an improved, unobstructed point thereon and an associated stylet.
Patent DE-69637256-T2 (DE)
Inventor: WINCOTT FRANCINE
IPC: C07H21/00
Filed: 1996-12-23
Granted: 2008-06-19
Abstract: This invention relates to chemical synthesis of 2'-O-methyl, 3'-O-methyl and 5'-O-methyl nucleosides, incorporation of novel chemical modifications in enzymatic nucleic acid molecules and improved methods for the synthesis of enzymatic nucleic acid molecules. <IMAGE>
Patent DE-69701029-T2 (DE)
Inventor: MAURIN VERONIQUE
IPC: A61K8/00
Filed: 1997-10-24
Granted: 2000-05-31
Abstract: New cosmetic composition (I) is in the form of, of contains, a transparent foaming gel comprising: at least one alkylether carboxylic acid with a fatty chain (II), at least one diol with a fatty chain (III), and water. Preferably (I) has Brookfield viscosity at 25 degrees C ≥ 1 Pa.s ( ≥ 4 Pa.s preferred). If ÄAKÜ and ÄAGÜ represent, respectively, the quantity by weight of (II) and (III) in (I), then the ratio ÄAGÜ:ÄAKÜ ≤ 1:3.5( ≤ 1:4 preferred), 1 ≤ ÄAKÜ ≤ 35 (2 ≤ ÄAKÜ ≤ 25 preferred), and 0.5 ≤ ÄAGÜ. (I) also contains at least one other ingredient (a surfactant, thickener, oil, colouring, preservative, perfume, filter, active hydro or lipophilic agent, or bulk). The water in (I) is a mineral water. (I) has pH 4.5-7.5. (II) is of formula R(OCnH2n)POACOOM; R =8-30C alkyl chain (10-22C, and more particularly 12-18C, preferred); A = 1-6C disubstituted alkane chain (1-3C, particularly 1C, preferred); M = H, an alkali metal, an alkali earth metal, NH4 integral+ or a cation of an organic base (H preferred); n = 2 or 3 (2 preferred); and p = 1 - 40 (2-30, particularly 3-20, preferred).
Patent DE-69701184-T2 (DE)
Inventor: AROSIO MASSIMO
IPC: F16L37/30
Filed: 1997-06-03
Granted: 2000-06-21
Abstract: Quick-release coupling comprising a male part (1) and a female part (15), where the female part (15) is composed of a valve stem (60) attached to an inner tubular body (59) so as to define a number of flow channels (62) and an outer body (16, 17) that houses sliders (63, 66) and means of locking and releasing the male part (1), in which coupling the female part (15) has an intermediate sleeve (35) that slides inside the outer body (16) and is attached to the inner tubular body (59), the outer body (16) has an inner stop shoulder (23) which defines the extended position of the sleeve (35), a sealing device forming a cross-section (37) of thrust influenced by the pressure of a fluid present in the female part (15), is present at the rear between the sleeve (35) and the outer body (17), the sleeve (35) is stressed from the rear by a pressure spring (39) and the outer body (16) has means for locking and releasing the sleeve. <IMAGE>
Patent DE-69706563-T2 (DE)
Inventor: SANTOSO IWAN
IPC: F01K13/02
Filed: 1997-12-05
Granted: 2002-07-11
Abstract: A method for blade temp estimation in a steam turbine utilizes measurement values including pressure and temperature at locations other than directly at the blades, principally at the input and output stages. Initially, blade temperature is simulated by using a water/steam cycle analysis program as well as by directed experiments. An artificial neural network (ANN) is trained by presenting the measurement values and the blade temp values. In a hybrid approach, 5 measured values are utilized. A subset of 4 parameter values is used for training the ANN and another subset of 3 values is used for performing a calculation for another intermediate parameter. Using the intermediate parameter and one of the 5 measured values, a blade temperature is calculated.
Patent DE-69718585-T2 (DE)
Inventor: WARIISHI KOJI
IPC: G11B7/254
Filed: 1997-09-30
Granted: 2003-08-07
Abstract: An information recording medium showing a high light-resistance has a recording layer containing a dye compound having the following formula (I-1) or (I-2): <CHEM> in which each of A<1>, A<2>, B<1> and B<2> is a substituent; each of Y<1> and Z<1> is a group of atoms required for forming a carbon ring or a heterocyclic ring; each of E and G is a group of atoms required for forming a conjugated double bond chain; X<1> is =O, =NR or =C(CN)2, wherein R is a substituent; X<2> is -O, -NR or -C(CN)2, wherein R is a substituent; each of L<1>, L<2>, L<3>, L<4> and L<5> is a methine group which may have a substituent; M<k+> is an onium ion containing a positively charged onium atom to which no hydrogen atom is attached; each of m and n is 0, 1 or 2; each of x and y is 0 or 1; and k is an integer of 1 to 10.
Patent DE-69722415-T2 (DE)
Inventor: ISAKSSON MIKAEL
IPC: H04L1/00
Filed: 1997-09-01
Granted: 2004-05-06
Abstract: In certain types ol transmission system using nQ,1M it may be desirable to use a control applications in muIticarrier snrstems with variable bitloading it is particularly desirible that the control channel data be separable from user data when the value of n. i.e the bitloading. or constellation identifier are unknown. Binary data is transmitted using nQAM modulation. The binary data comprises both user data and cointro,l clata. This means that a control channel is superimposed on a user data channel within the same nQAM constellation. Separation of said control data is lacilitated by arranging control data points to have either unique phase, or unique amplitude, values. These unique values are not employed for user data points.
Patent DE-69726146-T2 (DE)
Inventor: JALKANEN ERKKI
IPC: G01P15/08
Filed: 1997-06-19
Granted: 2004-09-16
Abstract: The invention relates to a sensor device for measuring attitude, acceleration or gravitational field and its gradient components. The device includes a spherical cavity (3) which contains a sensor substance in the form of a fluid or some other inertial material having fluidic properties. The cavity (3) is provided with measuring sensors or measuring electrodes (-x, +x; -y, +y; -z, +z) for three different coordinate axes x, y, z, all of said sensors responding to said common inertial mass which fills the cavity (3). Such assembled single compact measuring device can be used for determining any of the said quantities 3-dimensionally.
Patent DE-69732306-T2 (DE)
Inventor: EDWARDS DAVID A
IPC: A61K38/23
Filed: 1997-11-17
Granted: 2006-01-12
Abstract: Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or negatively charged therapeutic agent and a charged molecule of opposite charge for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the particles are made of a biodegradable material and have a tap density less than 0.4 g/cm<3> and a mass mean diameter between 5  mu m and 30  mu m, which together yield an aerodynamic diameter of the particles of between approximately one and three microns. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of poly(lactic acid) or poly(glycolic acid) or copolymers thereof. Alternatively, the particles may be formed solely of a therapeutic or diagnostic agent and a surfactant. Surfactants can be incorporated on the particule surface for example by coating the particle after particle formation, or by incorporating the surfactant in the material forming the particle prior to formation of the particle. Exemplary surfactants include phosphoglycerides such as dipalmitoyl phosphatidylcholine (DPPC). The particles can be effectively aerosolized for administration to the respiratory tract to permit systemic or local delivery of wide a variety of therapeutic agents. Formation of complexes of positively or negatively charged therapeutic agents with molecules of opposite charge can allow control of the release rate of the agents into the blood stream following administration.
Patent DE-69800784-T2 (DE)
Inventor: MOCHIZUKI CHITOSHI
IPC: C01B31/04
Filed: 1998-06-05
Granted: 2001-10-25
Abstract: A graphitising electric furnace comprises a furnace body (1) having a carbon powder inlet (4) centrally at the top and a graphite powder collecting port (7) opposed thereto centrally at the bottom which lie on a first hypothetical line (O). Means (3) are provided for continuously supplying carbon powder to the inlet (4) and means (6) are provided for continuously removing graphite powder from the collecting port (7). At least one pair of opposed electrodes (9a, 9b), which lie on second hypothetical line are provided on the inner wall of the furnished body (1). The two electrodes lie on a second hypothetical line. A graphitising area (8) is defined between the inlet (4) and collecting port (7). The first (O) and second hypothetical lines intersect at the centre of the graphitising area (8). <IMAGE>